SINOMED(SH:688108) Zheng Quan Zhi Xing·2025-08-29 17:46Summary of Key Points Core Viewpoint - The announcement details the shareholding status and a planned share reduction by a major shareholder of Sino Medical Science Technology Co., Ltd. due to personal funding needs [1][2]. Shareholding Status - As of the announcement date, the major shareholder, Mr. Guo Yanchao, holds 20,840,854 shares, representing 5.01% of the total shares of the company [2]. - Mr. Guo acquired 340,854 shares through secondary market trading, which accounts for 0.08% of the total shares [1]. Reduction Plan Details - Mr. Guo plans to reduce his holdings by up to 168,000 shares, which is not more than 0.04% of the total share capital, through block trading within three months from September 22, 2025, to December 21, 2025 [2]. - The shares to be reduced are sourced from shares acquired through competitive bidding in the secondary market [2]. Previous Reduction Activity - In the past 12 months, Mr. Guo has reduced his holdings by 1,930,000 shares, which is 0.46% of the total shares, at a price range of 12.80 to 12.90 yuan per share [2]. Compliance and Regulations - The reduction plan complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [3]. - The major shareholder has no other arrangements regarding the reduction and has not made any commitments regarding shareholding changes [2][3].